Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE

During the American College of Rheumatology (ACR) Convergence 2020, several presentations discussed data on the use of anifrolumab to treat patients with systemic lupus erythematosus (SLE). DocWire News interviewed Richard Furie, MD, Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, to discuss two abstracts, Early and Sustained Reduction in Severity of Skin Disease … Continue reading Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE